Business Description
Ovid Therapeutics Inc
NAICS : 325412
SIC : 2834
ISIN : US6904691010
Description
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential in-class mechanism of action.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 6.61 | |||||
| Equity-to-Asset | 0.61 | |||||
| Debt-to-Equity | 0.18 | |||||
| Debt-to-EBITDA | -0.28 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 1/9 | |||||
| Altman Z-Score | -0.67 | |||||
| Beneish M-Score | -3.28 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -69.7 | |||||
| 3-Year EBITDA Growth Rate | 16.2 | |||||
| 3-Year EPS without NRI Growth Rate | 17.9 | |||||
| 3-Year FCF Growth Rate | 9.9 | |||||
| 3-Year Book Growth Rate | 23.2 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 44.09 | |||||
| 9-Day RSI | 48.61 | |||||
| 14-Day RSI | 49.12 | |||||
| 6-1 Month Momentum % | -11.36 | |||||
| 12-1 Month Momentum % | -3.9 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 9.55 | |||||
| Quick Ratio | 9.55 | |||||
| Cash Ratio | 9.22 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -2.4 | |||||
| Shareholder Yield % | -0.06 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -15122.96 | |||||
| Net Margin % | -13351.53 | |||||
| FCF Margin % | -11713.52 | |||||
| ROE % | -47.32 | |||||
| ROA % | -37.18 | |||||
| ROIC % | -192.11 | |||||
| ROC (Joel Greenblatt) % | -385.77 | |||||
| ROCE % | -44.92 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 523.98 | |||||
| PB Ratio | 2.49 | |||||
| Price-to-Tangible-Book | 2.49 | |||||
| EV-to-EBIT | -2.25 | |||||
| EV-to-EBITDA | -2.31 | |||||
| EV-to-Revenue | 339.94 | |||||
| EV-to-Forward-Revenue | 332.26 | |||||
| EV-to-FCF | -2.97 | |||||
| Price-to-Net-Current-Asset-Value | 4.11 | |||||
| Price-to-Net-Cash | 4.4 | |||||
| Earnings Yield (Greenblatt) % | -44.44 | |||||
| FCF Yield % | -21.05 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:OVID
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Ovid Therapeutics Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.392 | ||
| EPS (TTM) ($) | -0.75 | ||
| Beta | -0.21 | ||
| Volatility % | 55.85 | ||
| 14-Day RSI | 49.12 | ||
| 14-Day ATR ($) | 0.145889 | ||
| 20-Day SMA ($) | 3.156 | ||
| 12-1 Month Momentum % | -3.9 | ||
| 52-Week Range ($) | 2.57 - 4.1389 | ||
| Shares Outstanding (Mil) | 70.71 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Ovid Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Ovid Therapeutics Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Ovid Therapeutics Inc Frequently Asked Questions
What is Ovid Therapeutics Inc(OVID)'s stock price today?
The current price of OVID is $3.09. The 52 week high of OVID is $4.14 and 52 week low is $2.57.
When is next earnings date of Ovid Therapeutics Inc(OVID)?
The next earnings date of Ovid Therapeutics Inc(OVID) is 2024-05-03 Est..
Does Ovid Therapeutics Inc(OVID) pay dividends? If so, how much?
Ovid Therapeutics Inc(OVID) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers